LHC Group - common stock (LHCG): Price and Financial Metrics
LHC Group - common stock (LHCG)
Today's Latest Price: $220.91 USD
Updated Oct 20 4:00pm
Add LHCG to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
LHCG Stock Summary
- With a price/earnings ratio of 59.21, LHC Group Inc P/E ratio is greater than that of about 84.82% of stocks in our set with positive earnings.
- Of note is the ratio of LHC Group Inc's sales and general administrative expense to its total operating expenses; 98.8% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -57.75%, LHC Group Inc's debt growth rate surpasses merely 4.54% of about US stocks.
- Stocks that are quantitatively similar to LHCG, based on their financial statements, market capitalization, and price volatility, are SNA, BMI, DECK, COLM, and SAM.
- Visit LHCG's SEC page to see the company's official filings. To visit the company's web site, go to www.lhcgroup.com.
LHCG Stock Price Chart Interactive Chart >
LHCG Price/Volume Stats
| Current price | $220.91 | 52-week high | $231.79 |
| Prev. close | $222.26 | 52-week low | $100.00 |
| Day low | $220.58 | Volume | 88,200 |
| Day high | $225.84 | Avg. volume | 308,375 |
| 50-day MA | $208.71 | Dividend yield | N/A |
| 200-day MA | $166.02 | Market Cap | 6.98B |
LHC Group - common stock (LHCG) Company Bio
LHC Group is a national provider of post-acute healthcare services, providing quality, cost-effective healthcare to patients within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice and community-based services and provides inpatient care through long-term acute care hospitals. The company was founded in 1994 and is based in Lafayette, Louisiana.
LHCG Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $220.91 | $1312 | 490% |
Below please find a table outlining a discounted cash flow forecast for LHCG, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that LHC Group Inc ranked in the 79th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for LHC Group Inc ended up being:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 98. Its equity weight surpasses that of 83.88% of free cash flow generating stocks in the Healthcare sector.
- The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than merely 8.24% of the free cash flow producing stocks we're observing.
- LHCG's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 49.77% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 479% |
| 1% | 485% |
| 2% | 490% |
| 3% | 496% |
| 4% | 502% |
| 5% | 508% |
LNTH, INVA, HAE, PRSC, and TVTY can be thought of as valuation peers to LHCG, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...